Journal of Geriatric Cardiology 2012/9:4 PP.389-400
During the last 20 years, the management of heart failure has significantly improved by means of new pharmacotherapies, more timely invasive treatments and device assisted therapies. Indeed, advances in mechanical support, namely with the development of more efficient left ventricular assist devices (LVADs), and the total artificial heart have reduced mortality and morbidity in patients awaiting transplantation, so much so, that LVADs are now approved of as a strategy for destination therapy. In this review, the authors describe in detail the current basic indications, functioning modalities, main limitations of surgical LAVDs, total artificial heart development, and percutaneous assist devices, trying to clarify this complex, but fascinating topic.
1 Stewart S, MacIntyre K, Hole DJ, et al. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001; 3: 315-322.
2 Klotz S, Loeher A, Drees G, et al. Surgical therapy of end-stage heart failure. State of the art 2006. Herz 2006; 31: 445-454.
3 Allen LA, Felker GM. Advances in the surgical treatment of heart failure. Curr Opin Cardiol 2008; 23: 249-253.
4 Swedberg K, Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Am J Cardiol 1988; 62: 60A-66A.
5 Domanski MJ, Krause-Steinrauf H, Massie BM, et al. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail 2003; 9: 354-363.
6 The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 1: 293-302.
7 Cleland JGF, Khand A, Clark AC. The heart failure epidemiology: Exactly how big is it? Eur Heart J 2001; 22: 623-665.
8 Gardner R, Mc Donagh T, Mac D, et al. Who needs a heart transplant? Eur Heart J 2006; 27: 770-772.
9 Butler J, Khadim G, Paul KM, et al. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol 2004; 43: 787-793.
10 Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult heart transplant report—2005. J Heart Lung Transplant 2005; 24: 945-955.
11 Almenar-Bonet L. Spanish Working Groups on Heart Transplantation. Spanish heart transplantation registry. 18th official report of the Spanish Society of Cardiology working group on heart failure, heart transplantation and associated therapies (1984-2006). Rev Esp Cardiol 2007; 60: 1177-1187.
12 Metra M, Ponikowski P, Dickstein K, et al. Advanced chronic heart failure: a position statement from the Study Group on advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2007; 9: 689-694.
13 Komoda T, Hetzer R, Lehmkuhl HB. Destiny of candidates for heart transplantation in the Eurotransplant heart allocation system. Eur J Cardiothor Surg 2008; 34: 301-306.
14 Strüber M, Sander K, Lahpor J, et al. Heart Mate II left ventricular assist device; early European experience. Eur J Cardiothoracic Surg 2008; 34: 289-294.
15 Cooley DA. The total artificial heart. Nat Med 2003; 9: 108-111.
16 Bücherl ES, Henning E, Baer P, et al. Status of the artificial heart program in Berlin. World J Surg 1985; 9: 103-115.
17 Cooley DA, Liotta D, Hallman GL, et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 1969; 24: 723-730.
18 Pennington DG, Kanter KR, McBride LR, et al. Seven years experience with the Pierce-Donachy ventricular assist device. J Thorac Cardiovasc Surg 1988; 96: 9014-9021.
19 Pennington DG, Reedy JE, Swartz MT, et al. Univentricular versus biventricular assist device support. J Heart Lung Trans-plant 1991; 10: 258-263.
20 Frazier OH. First use of an untethered, vented electric left ventricular assist device for long term support. Circulation 1994; 89: 2908-2914.
21 Vetter HO, Kaulbach HG, Schmitz C, et al. Experience with the Novacor left ventricular assist System as a bridge to cardiac transplantation, including a new wearable system. J Thorac Cardiovasc Surg 1995; 109: 74-80.
22 Rose EA, Moskowitz AJ, Heitjan DF, et al. Long term mech-anical left ventricular assistance for end stage heart failure. N Engl J Med 2001; 345: 1434-1443.
23 Rothenburger M, Wilhelm MJ, Hammel D, et al. Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 2002; 106: I189-I192.
24 Miller LW, Pagani FD, Russell SD, et al. Use of continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357: 885-896.
25 Esmore D, Spratt P, Larbalestier R, et al. VentrAssist left ventricular assist device: clinical trial results and clinical development plan update. Eur J Cardiothorac Surg 2007; 32: 735-744.
26 Wieselthaler GM, Riedl M, Schima H, et al. Endocrine function is not impaired in patients with a continuous MircoMed-DeBakey axial flow pump. J Thorac Cardiovasc Surg 2007; 133: 2-6.
27 Radovancevic B, Vrtovec B, de Kort E, et al. End-organ function in patients on long term circulatory support with continuous—or pulsatile—flow assist devices. J Heart Lung Transplant. 2007; 26: 815-818.
28 Zimpfer D, Wieselthaler G, Czerny M, et al. Neurocognitive function in patients with ventricular assist devices: a comparison of pulsatile and continuous blood flow devices. Asaio J 2006; 52: 24-27.
29 Akimoto T, Yamazaki K, Litwak P, et al. Rotary blood pump flow spontaneously increases during exercise under constant pump speed: results of a chronic study. Artif Organs 1999; 23:797-801.
30 Geisen U, Heilmann C, Beyersdorf F, et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008; 33: 679-684.
31 Kirklin JK, Naftel DC. Mechanical circulatory support: registering a therapy in evolution. Circ Heart Fail 2008; 1: 200-205.
32 Holman WL, Davies JE, Rayburn BK, et al. Treatment of end-stage heart disease with outpatient ventricular assist devices. Ann Thorac Surg 2002; 73: 1489-1493.
33 Frazier OH, Rose EA, Oz MC, et al. HeartMate LVAS Investigators Left ventricular assist system. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001; 122: 1186-1195.
34 Strauch JT, Spielvogel D, Haldenwang PL, et al. Recent improvements in outcome with the Novacor left ventricular assist device. J Heart Lung Transplant 2003; 22: 674-680.
35 Slaughter MS, Tsui SS, El-Banayosy A, et al. IVAD Study Group Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device. J Thorac Cardiovasc Surg 2007; 133: 1573-1580.
36 Miller LW, Pagani FD, Russell SD, et al. HeartMate II Clinical Investigators Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357: 885-896.
37 Frazier OH, Myers TJ, Westaby S, et al. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg 2004; 77: 133-142.
38 Goldstein DJ. Worldwide experience with the MicroMed DeBakey ventricular assist device as a bridge to transplantation. Circulation 2003; 108(Suppl. I): 272-277.
39 Samuels LE, Holmes EC, Garwood P, et al. Initial experience with the Abiomed AB 5000 ventricular assist device system. Ann Thorac Surg 2005; 80: 309-312.
40 Hoshi H, Shinshi T, Takatani S. Third-generation blood pumps with mechanical noncontact magnetic bearings. Artif Organs 2006; 30: 324-338.
41 Kirsch M, Vermes E, Boval B, et al. Four years of circulatory support with the INCOR axial pump from Berlin Heart. Arch Mal Coeur Vaiss 2007; 100: 967-970.
42 LaRose JA, Tamez D, Ashenuga M, et al. Design concepts and principle of operation of the heartware ventricular assist system. ASAIO J 2010; 56: 285-289.
43 Farrar DJ, Bourque K, Dague CCP, et al. Design features, developmental status, and experimental results with the heart mate III centrifugal left ventricular assist system with a magnetically levitated rotor. ASAIO J 2007; 53: 310-315.
44 Morshuis M, el-Banayosy A, Arusoglu L, et al. European experience of DuraHeart magnetically levitated centrifugal left assist system. Eur J Cardiothorac Surg 2009; 35: 1020-1028.
45 Meyns B, Ector J, Rega F, et al. First human use of partial left ventricular heart support with the Circulite synergy micro-pump as a bridge to cardiac transplantation. Eur Heart J 2008; 29: 2582.
46 Nasir A, Bonde P, Graham ANJ. Ventricular assist device therapy in post-cardiotomy cardiogenic shock: historical outcomes and current trends. Interact Cardiovasc Thorac Surg 2012; 14: 585-587.
47 Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995; 222: 327-338.
48 Richenbacher WE, Naka J, Raines EP, et al. REMATCH Investigators Surgical management of patients in the REMATCH Trial. Ann Thorac Surg 2003; 75(6 Suppl.): S86-S92.
49 Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients waiting heart transplantation. N Engl J Med 1007; 357: 885-896.
50 Starling RC, Naka Y, Boyle AJ. Results of the post-FDA-approval study with continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011; 10; 57: 1890-1898.
51 Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251.
52 Holman WL, Kormos RL, Naftel DC, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009; 28: 44-50.
53 Wieselthaler GGM, O’Driscoll G, Jansz P, et al. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010; 29: 822-824.
54 Aronson K. Evaluation of Heartware HVAD left ventricular assist device system for the treatment of advanced heart failure: results of the ADVANCE bridge-to-transplant Trial. Presentation at the AHA meeting, Chicago, Illinois, USA, 13-17 November 2010.
55 Copeland JG, Smith RG, Arabia FA, et al. Comparison of the CardioWest total artificial heart, the Novacor left ventricular assist system, and the Thoratec ventricular assist system in bridge to transplantation. Ann Thorac Surg 2001; 71: S92-S97.
56 Copeland JG, Smith RG, Bose RK, et al. Risk factors analysis for bridge to transplantation with the CardioWest total artificial heart. Ann Thorac Surg 2008; 85: 1639-1645.
57 Samuels L. The AbioCor totally implantable replacement heart. Am Heart Hosp J 2003; 1: 91-96.
58 Dowling RD, Gray Jr LA, Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004; 127: 131-141.
59 Frazier OH, Dowling RD, Gray LA Jr, et al. The total artificial heart: where do we stand. Cardiology 2004; 101: 117-121.
60 Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant 2010; 29: S1-S39.
61 Rossi M, Serraino GF, Jiritano F, et al. What is the optimal anticoagulation in patients with a left ventricular assist device? Inter Cardiovasc Thor Surg 2012; 1-8.
62 Neragi-Miandoab S, Goldstein D, Bello R, et al. Right ventricular dysfunction following continuous flow left ventricular assist device placement in 51 patients: predicators and outcomes. J Cardiothorac Surg 2012; 7: 60.
63 Potapov EV, Stpanenko A, Dandel M, et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular dysfunction after implantation of a left ventricular assist device. J Heart Lung Transplant 2008; 27: 1275-1281.
64 Clegg AJ, Scott DA, Loveman E, et al. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Heath Technol Assess 2005; 9: 1-132.
65 Matsumiya G, Saitoh S, Sawa Y. Extracorporeal assist circulation for heart failure. Cir J 2009; 73 (Suppl A): 42-47.
66 Smedira NG, Moazami N, Golding CM, et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at 5 years. J Thorac Cardiovasc Surg 2001; 122: 92-102.
67 Thiele H, Lauer B, Hambrecht R, et al. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001; 104: 2917-2922.
68 LaRocca GM, Shimbo D, Rodriguez CJ, et al. The Impella recover LP 5.0 left ventricular assist device: a bridge to coronary artery bypass grafting and cardiac transplantation. J Am Soc Echocardiogr 2006; 19: 468.e5-e7.
69 Sjauw KD, Konorza T, Erbel R, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol 2009; 54: 2430-2434.
70 Vranckx P, Schultz CJ, Eindhoven JA, et al. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG. Catheter Cardiovasc Interv 2009; 74: 302-310.
71 Kucukaksu S, Ergenoglu MU, Yildiz CE, et al. High-risk left main coronary artery bypass surgery supported by the Impella Recover LP 2.5 assist device: an alternative insertion technique. Heart Surg Forum 2009; 12: E324-E326.
72 Rajagopal V, Steahr G, Wilmer CI, et al. A novel percutaneous mechanical biventricular bridge to recovery in severe cardiac allograft rejection. J Heart Lung Transplant 2010; 29: 93-95.
73 Atoui R, Samoukovic G, Al-Tuwaijri F, et al. The use of the Impella LP 2.5 percutaneous microaxial ventricular assist device as hemodynamic support during high-risk abdominal surgery. J Card Surg 2009; 25: 238-240.
74 Andrade JG, Al-Saloos H, Jeewa A, et al. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump. J Heart Lung Transplant 2010; 29: 96-97.
75 Gregoric ID, Loyalka P, Radovancevic R, et al. TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. Ann Thorac Surg 2009; 88: 1822-1826.